OTP Town Hall: Cell Therapy CMC Readiness for Late-Stage INDs
Office of Therapeutic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration · July 23, 2026
The FDAs Office of Therapeutic Products hosted a virtual town hall on CMC expectations and readiness for late-stage INDs for cell therapy and tissue-engineered products, answering pre-submitted and live questions from product developers and researchers.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.